ChemoCentryx, Inc. Announces Appointment of Health Care Insurance Executive Ira Klein, MD, to Company’s Board of Directors

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MOUNTAIN VIEW, Calif., May 28, 2013 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc. (Nasdaq:CCXI) has announced the appointment of Ira Klein, MD, MBA, FACP, to its Board of Directors. Most recently the Chief of Staff to the Chief Medical Officer (CMO) at Aetna, Dr. Klein has been newly appointed as National Medical Director, Clinical Thought Leadership to that organization. At Aetna, Dr. Klein is responsible for promoting the strategic efforts of the office of the CMO, including creating and deploying clinical programs, and facilitating integration and clinician development.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC